Clinical Chemistry Analyzers Detect Drugs of Abuse

Clinical chemistry analyzers use new reagents to detect 10 drugs of abuse (DoA) in human urine.

DoA tested for include cannabinoids (THC), cocaine metabolite, EDDP, ecstasy (MDMA), methadone, opiates, amphetamines, barbiturates, benzodiazepines, and ethanol.

Randox (Crumlin, UK) have launched DoA reagents for use on its RX series of clinical chemistry analyzers, RX Daytona and RX Imola. The analyzers and reagents provide systems that offer time, labor, and cost savings.

The RX Daytona is a compact, fully automated, random access analyzer with a throughput of 180 photometric tests and 270 independent security evaluators (ISE) tests per hour. The RX Imola is a fully automated random access benchtop analyzer capable of performing 400 photometric tests per hour and 240 ISE tests per hour. The analyzers are suitable for all types and sizes of laboratories.

Randox DoA assays are precise, stable, and accurate. The new assays are suited for use in police/crime laboratories, hospital laboratories, prison laboratories, as well as private screening laboratories. A comprehensive range of quality control sera is available.

Randox is an international diagnostics company that develops, manufactures, and markets clinical diagnostic products worldwide. Core products include clinical chemistry analyzers and reagents; biochip array technology; quality controls; and recombinant proteins and antibodies.

Related Links:
Randox